439 related articles for article (PubMed ID: 18483232)
21. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
[TBL] [Abstract][Full Text] [Related]
22. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
[TBL] [Abstract][Full Text] [Related]
23. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
[TBL] [Abstract][Full Text] [Related]
24. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
25. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
[TBL] [Abstract][Full Text] [Related]
26. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
[TBL] [Abstract][Full Text] [Related]
27. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
[TBL] [Abstract][Full Text] [Related]
28. [Influence of high- and low-osmolality contrast media on renal function in children].
Chen CY; Cao L; Chen DK; Chu M; Tu J
Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):280-4. PubMed ID: 16780650
[TBL] [Abstract][Full Text] [Related]
29. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat.
Seeliger E; Becker K; Ladwig M; Wronski T; Persson PB; Flemming B
Radiology; 2010 Aug; 256(2):406-14. PubMed ID: 20529990
[TBL] [Abstract][Full Text] [Related]
30. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Iodixanol and Iopromide in Patients With Renal Insufficiency and Congestive Heart Failure Undergoing Coronary Angiography by Hemodynamic Monitoring.
Qian G; Yang YQ; Dong W; Cao F; Chen YD
Angiology; 2017 Nov; 68(10):907-913. PubMed ID: 28401790
[TBL] [Abstract][Full Text] [Related]
32. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
34. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
35. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
36. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
[TBL] [Abstract][Full Text] [Related]
37. Systemic Hypotension Following Intravenous Administration of Nonionic Contrast Medium During Computed Tomography: Iopromide Versus Iodixanol.
Widmann G; Bale R; Ulmer H; Putzer D; Schullian P; Wiedermann FJ; Lederer W
Anesth Analg; 2018 Mar; 126(3):769-775. PubMed ID: 28806208
[TBL] [Abstract][Full Text] [Related]
38. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD
Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017
[TBL] [Abstract][Full Text] [Related]
39. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
Thomsen HS; Morcos SK
Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
[TBL] [Abstract][Full Text] [Related]
40. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
